Page 7,142«..1020..7,1417,1427,1437,144..7,1507,160..»

Mountain West and Conference USA association moving forward — Macrobid Without A Prescription » Online Pharmacy

Posted: Published on February 14th, 2012

By News Release on Feb 14, 2012 in News, Sports DALLAS, Texas- Presidents and chancellors from 16 universities met in Dallas Sunday to discuss future conference membership plans and agreed to work on forming a new intercollegiate athletic association that would begin competition in the 2013-14 academic year.   According to the press release from the Mountain West Conference, “This presidentially-led association will ensure stability and be built upon the principles of operating at the highest level of integrity and sportsmanship, enhancing the student-athlete academic and competitive experience, bringing fiscal discipline into athletics and ensuring competitive fairness.”   “This is an exciting development that will stabilize the current conferences and create the first truly national conference with members in five time zones and television viewership from coast to coast. This partnership brings together like-minded institutions to improve the integrity and stability of intercollegiate athletics,” said UNLV President Neal Smatresk. “We are moving our plans forward rapidly and expect to complete our conversations in the near future. Look for further announcements soon as we work together on this exciting new venture.” Universities involved in the discussions were the United States Air Force Academy, University of Alabama at Birmingham, Colorado State University, East … Continue reading

Posted in Online Pharmacy | Comments Off on Mountain West and Conference USA association moving forward — Macrobid Without A Prescription » Online Pharmacy

Firefighter falls nearly 20 feet through roof at Navarro Pharmacy

Posted: Published on February 14th, 2012

By Monique O. Madan, The Miami Herald 12:16 p.m. EST, February 14, 2012 A major fire at a Navarro Pharmacy in Little Havana sent a Miami firefighter to the hospital Tuesday morning, according to the Miami Fire Department. Capt. Ray Pampin, 48, was taken to the Ryder Trauma Center at Jackson Memorial Hospital after falling 15 to 20 feet. According to spokesman Ignatius Carroll, Pampin, a 25-year veteran, was checking the roof for hot spots but fell through an area that was covered by debris. "They were checking an area by an air-conditioning duct," Carroll said. "While doing that, he fell through a vent covered by debris. Crews called 'Mayday' and quickly treated him." Pampin is in stable condition. The fire was reported at 12:30 a.m. Tuesday after dispatch received a call after an automatic alarm went off at the pharmacy, 1243 SW Eighth St. "Units saw smoke coming from the doors," Carroll said. "They touched the door and knew it was a working fire." More than 40 firefighters fought the blaze, which took more than one hour to control. Carroll said they have ruled out arson. "The fire was determined to be accidental," he said. "We are trying to … Continue reading

Posted in Pharmacy | Comments Off on Firefighter falls nearly 20 feet through roof at Navarro Pharmacy

Navarro Pharmacy fire in Little Havana sends firefighter to hospital

Posted: Published on February 14th, 2012

A major fire at a Navarro Pharmacy in Little Havana sent a Miami firefighter to the hospital Tuesday morning, according to the Miami Fire Department. Capt. Ray Pampin, 48, was taken to the Ryder Trauma Center at Jackson Memorial Hospital after falling 15 to 20 feet. According to spokesman Ignatius Carroll, Pampin, a 25-year veteran, was checking the roof for hotspots but fell through an area that was covered by debris. “They were checking an area by an air-conditioning duct,” Carroll said. “While doing that, he fell through a vent covered by debris. Crews called ‘Mayday’ and quickly treated him.” Pampin is in stable condition. The fire was reported at 12:30 a.m. Tuesday after dispatch received a call after an automatic alarm went off at the pharmacy, 1243 SW Eighth St.. “Units saw smoke coming from the doors,” Carroll said. “They touched the door and knew it was a working fire.” More than 40 firefighters fought the blaze, which took more than one hour to control. Carroll said they have ruled out arson. “The fire was determined to be accidental,” he said. “We are trying to pinpoint if machinery was placed by flammable products.” As firefighters made their way through … Continue reading

Posted in Pharmacy | Comments Off on Navarro Pharmacy fire in Little Havana sends firefighter to hospital

Pharmacy grads will have jobs, minister says

Posted: Published on February 14th, 2012

By Lisa J. Ariffin KUALA LUMPUR, Feb 14 — Datuk Seri Liow Tiong Lai assured unemployed pharmacy graduates today they will have jobs soon. The health minister blamed the delay of a salary scale for civil servants under a revised government remuneration scheme for the lack of jobs. “Lately, the bit of delay of employing our pharmacists into our system is due to the new SBPA that has been deferred,” Liow (picture) said. He assured the new pharmacists they will be recruited as soon as possible. Liow said the government was working to bridge the public-private healthcare divide and will soon be able to offer more jobs to new pharmacy graduates. “To say that we don’t have enough positions to cater is not true,” Liow said, responding to recent reports highlighting pharmacy graduates who claim they have been jobless as far back as eight months ago. “In fact we are liberalising our policy, we would like to allow our pharmacists to work either in government or private (sectors),” he told reporters following the launch of a pharmaceutical industry fact here. He said his ministry had even liberated attachment conditions for fresh graduates and was taking in more pharmacy graduates annually. … Continue reading

Posted in Pharmacy | Comments Off on Pharmacy grads will have jobs, minister says

Dr. Ramaswamy on Dormant Tumor Cells and Resistance – Video

Posted: Published on February 14th, 2012

13-02-2012 12:31 Sridhar Ramaswamy, MD, Tucker Gosnell Investigator and Associate Professor of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Broad Institute of Harvard and MIT, and Harvard Stem Cell Institute, discusses ongoing research into drug tolerance and resistance, specifically the roll of dormant cancer cells. If a tumor goes into remission as a result of a cancer drug and then recurs it is likely that the tumor will still respond to the initial treatment. In the dormant state the cells are resistance, in the original they are sensitive. The exact mechanism behind this has yet to be discovered. In some cases giving a course, stopping, and then continuing later on can create an additive effect, an idea that Ramaswamy calls a drug holiday. A comparison is underway between drug and non-drug induced dormant cells in order to find the mechanism that causes resistance. The ultimate goal of the research is to be able to predict and stop drug resistance. Continued here: Dr. Ramaswamy on Dormant Tumor Cells and Resistance - Video … Continue reading

Comments Off on Dr. Ramaswamy on Dormant Tumor Cells and Resistance – Video

U-M Human Embryonic Stem Cell Line Placed On National Registry for Researchers

Posted: Published on February 14th, 2012

To: EDUCATION, MEDICAL AND NATIONAL EDITORS Line is first from U-M accepted to the U.S. National Institutes of Health registry, now available for federally-funded research ANN ARBOR, Mich., Feb. 14, 2012 /PRNewswire-USNewswire/ -- The University of Michigan's first human embryonic stem cell line will be placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the first of the stem cell lines derived at the University of Michigan to be placed on the registry. The line, known as UM4-6, is a genetically normal line, derived in October 2010 from a cluster of about 30 cells removed from a donated five-day-old embryo roughly the size of the period at the end of this sentence. That embryo was created for reproduction but was no longer needed for that purpose and was therefore about to be discarded. "This is significant, because acceptance of these cells on the registry demonstrates our attention to details of proper oversight, consenting, and following of NIH guidelines established in 2009," says Gary Smith, Ph.D., who derived the line and also is co-director of the U-M Consortium for Stem Cell Therapies, part of the A. Alfred Taubman Medical Research Institute. "It … Continue reading

Comments Off on U-M Human Embryonic Stem Cell Line Placed On National Registry for Researchers

U-M human embryonic stem cell line placed on national registry

Posted: Published on February 14th, 2012

Public release date: 14-Feb-2012 [ | E-mail | Share ] Contact: Mary F. Masson mfmasson@umich.edu 734-764-2220 University of Michigan Health System ANN ARBOR, Mich. ? The University of Michigan's first human embryonic stem cell line will be placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the first of the stem cell lines derived at the University of Michigan to be placed on the registry. The line, known as UM4-6, is a genetically normal line, derived in October 2010 from a cluster of about 30 cells removed from a donated five-day-old embryo roughly the size of the period at the end of this sentence. That embryo was created for reproduction but was no longer needed for that purpose and was therefore about to be discarded. "This is significant, because acceptance of these cells on the registry demonstrates our attention to details of proper oversight, consenting, and following of NIH guidelines established in 2009," says Gary Smith, Ph.D., who derived the line and also is co-director of the U-M Consortium for Stem Cell Therapies, part of the A. Alfred Taubman Medical Research Institute. "It now makes the line available to researchers who … Continue reading

Comments Off on U-M human embryonic stem cell line placed on national registry

Vet offers stem cell therapy for dogs

Posted: Published on February 14th, 2012

COLUMBIA, SC (WIS) - Cutting-edge arthritis treatment for our four-legged family members is now available in Columbia. Banks Animal Hospital is the first in the area to offer in-house Stem Cell therapy. It uses your pets own body to heal itself. Take 13-year-old Maggie, for example. The energetic pup has a limp that usually keeps her from jumping or going up stairs. "Today when everybody's out there filming her little limp it's not as pronounced because she wants to please," said Maggie's owner, Beth Phibbs. "She's just a great dog." But a great attitude wasn't enough to repair a bad case of cervical spine arthritis. So Monday, Beth brought Maggie to Banks Animal Hospital for the Stem Cell therapy. Like many, Beth had never heard of Stem Cell work in animals. "Until Dr. Banks mentioned it to me I was like, beg your pardon?" "There's no down side, no side effects because you're using your own cells," said Dr Ken Banks. Banks and his staff first gather some of Maggie's blood and fat. Both are good places to find the repair cells they're after. Adult stem cells, not the controversial embryonic kind, are then separated and spun down. "The repair … Continue reading

Comments Off on Vet offers stem cell therapy for dogs

Scientists Repair Heart Attack Damage Using Patient's Own Stem Cells To Regrow Healthy Heart Muscle

Posted: Published on February 14th, 2012

Featured Article Academic Journal Main Category: Stem Cell Research Also Included In: Cardiovascular / Cardiology Article Date: 14 Feb 2012 - 2:00 PST email to a friend   printer friendly   opinions   Current Article Ratings: Patient / Public: 5 (1 votes) Healthcare Prof: Details of a small clinical trial published in The Lancet on Tuesday reveal how scientists helped patients with hearts damaged by heart attack to re-grow healthy heart muscle and reduce scar tissue with an infusion of stem cells taken from the patients' own hearts. Leading international cardiologist and heart researcher Dr Eduardo Marbán, who is director of the Cedars-Sinai Heart Institute in Los Angeles and Mark S. Siegel Family Professor, is senior author of the study. He told the press what they saw in the trial: "... challenges the conventional wisdom that, once established, scar is permanent and that, once lost, healthy heart muscle cannot be restored." In 2009, Marbán and his team had already shown it is possible, following a heart attack, to grow specialized stem cells from the patient's own heart tissue (called cardiosphere-derived cells or CDCs), inject them back into the patient's damaged heart, and see they reduce scars, increase muscle and boost … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Scientists Repair Heart Attack Damage Using Patient's Own Stem Cells To Regrow Healthy Heart Muscle

Neuralstem Announces Closing of $5.2-Million Registered Direct Offering

Posted: Published on February 14th, 2012

ROCKVILLE, Md., Feb. 14, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced today that it has closed on its previously announced registered direct placement of 5,200,000 shares of common stock at a price of $1.00 per share, and 5,200,000 warrants each with an exercise price of $1.02 per share and exercisable starting six months from the issuance date for a term of five years. The company received aggregate gross proceeds of $5,200,000, which will be used for general corporate purposes, including ongoing U.S. clinical trials. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) T.R. Winston & Company, LLC acted as the exclusive placement agent for the offering. About Neuralstem Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease, and has been awarded orphan status designation by the FDA. In addition to ALS, the company is also targeting major central nervous system conditions with its cell therapy platform, including spinal cord injury, … Continue reading

Posted in FDA Stem Cell Trials | Comments Off on Neuralstem Announces Closing of $5.2-Million Registered Direct Offering

Page 7,142«..1020..7,1417,1427,1437,144..7,1507,160..»